Health Canada clears Zargis' Cardioscan
This article was originally published in Clinica
Zargis Medical's Cardioscan has been cleared for sale in Canada. The software, which analyses cardiac sounds to help identify and classify suspected heart murmurs, connects wirelessly to a Bluetooth-enabled electronic stethoscope. It can help physicians to determine which patients should be referred to echocardiography and which should not – these tests are conclusive, but very expensive. Stamford, Connecticut-based Zargis plans to launch the product immediately in Canada. The software, along with 3M's Littmann Electronic Stethoscope Model 3200, received Popular Science magazine's "innovation of the year" award in November. Cardioscan was cleared by the US FDA in 2004.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.